Pascal Le Corre

Prof. Pascal Le Corre

Université de Rennes 1
+1
orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
MBMathilde Bories
Mathilde Bories
GBGUILLAUME BOUZILLE
GUILLAUME BOUZILLE
MCMarc Cuggia
Marc Cuggia
Pascal Le CorrePascal Le Corre
Pascal Le Corre
Drug–drug interactions (DDI) occurring with potentially inappropriate medications (PIM) are additional risk factors that may increase the inappropriate character of PIM. The aim of this study was (1) to describe the prevalence and severity of DDI in patients with PIM and (2) to evaluate the DDI specifically regarding PIM. This systematic review is based on a search carried out on PubMed and Web-of-Science from inception to June 30, 2020. We extracted data of original studies that assessed the prevalence of both DDI and PIM in elderly patients in primary care, nursing home and hospital settings. Four hundred and forty unique studies were identified: 91 were included in the qualitative analysis and 66 were included in the quantitative analysis. The prevalence of PIM in primary care, nursing home and hospital were 19.1% (95% confidence intervals (CI): 15.1–23.0%), 29.7% (95% CI: 27.8–31.6%) and 44.6% (95% CI: 28.3–60.9%), respectively. Clinically significant severe risk-rated DDI averaged 28.9% (95% CI: 17.2–40.6), in a hospital setting; and were approximately 7-to-9 lower in primary care and nursing home, respectively. Surprisingly, only four of these studies investigated DDI involving specifically PIM. Hence, given the high prevalence of severe DDI in patients with PIM, further investigations should be carried out on DDI involving specifically PIM which may increase their inappropriate character, and the risk of adverse drug reactions.

7 December 2016 in Hematological Oncology
Verified
Journal Article
Closed access
PDF file
CGCaroline Gay
Caroline Gay
DTDelphine Toulet
Delphine Toulet
Pascal Le CorrePascal Le Corre
Pascal Le Corre

15 March 2002 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Pascal Le CorrePascal Le Corre
Pascal Le Corre
JEJean Pierre Estèbe
Jean Pierre Estèbe
RCRozenn Clément
Rozenn Clément
LPLaure Du Plessis
Laure Du Plessis
FCFrançois Chevanne
François Chevanne
RVRoger Le Verge
Roger Le Verge

1 September 1999 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
GDGilles Dollo
Gilles Dollo
Pascal Le CorrePascal Le Corre
Pascal Le Corre
MCMarylene Chollet
Marylene Chollet
FCFrançois Chevanne
François Chevanne
MBMarcel Bertault
Marcel Bertault
RVRoger Le Verge
Roger Le Verge
Inclusion complexes between beta-cyclodextrin derivatives and 1, 2-dithione-3-thiones were studied in aqueous solution and in the solid state. Phase solubility study was used to evaluate the complexation in solution, at 37 degrees C, of three cyclodextrins, i. e., beta-cyclodextrin (betaCD), hydroxypropyl-beta-cyclodextrin (HPbetaCD), sulfobutyl ether-7-beta-cyclodextrin (SBE7betaCD), and four 1,2-dithiole-3-thiones, i.e., the parent compound dithiolethione (DTT), dimethyldithiolethione (DMDTT), 5-phenyldithiolethione (5PDTT), and anetholetrithione (ATT). Stability constants of the DTT complexes with HPbetaCD and SBE7betaCD were also determined spectrophotometrically using a nonlinear least-squares methodology. Differential scanning calorimetry (DSC) and scanning electronic microscopy (SEM) were used to characterize spray-dried complexes formed between 5PDTT and SBE7betaCD, ATT and SBE7betaCD. Dissolution studies using the USP paddle method were carried out in water at 37 degrees C for both ATT and 5PDTT binary systems with HPbetaCD and SBE7betaCD. Solubility enhancements were much greater with the more lipophilic ATT and 5PDTT compared to DTT and DMDTT, whatever the cyclodextrin used, in the rank order SBE7betaCD > HPbetaCD >> betaCD. Stability constants obtained (between 120 and 12800 mol(-1)) were also the highest for the more lipophilic drugs and in the same rank order SBE7betaCD > HPbetaCD >> betaCD. Results obtained by UV spectrophotometry were in good agreement with those obtained by phase-solubility study. DSC thermograms of spray-dried complexes of ATT and 5PDTT with HPbetaCD and SBE7betaCD lacked the endothermal peak of pure drug peak which was found for the physical mixtures (107 degrees C and 125 degrees C for ATT and 5PDTT, respectively). Finally, dissolution profiles of spray-dried inclusion complexes studied displayed a faster dissolution rate compared to physical mixtures and pure drugs. The present study showed that complexation of 1,2-dithiole-3-thiones with beta-cyclodextrin derivatives resulted in an increase in solubility, allowing intravenous formulation for bioavailability and metabolism studies and an increase in the dissolution rate of the drugs, which should be of interest for oral absorption of these lipophilic compounds.

20 September 1999 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
Pascal Le CorrePascal Le Corre
Pascal Le Corre
GDGilles Dollo
Gilles Dollo
FCFrançois Chevanne
François Chevanne
RVRoger Le Verge
Roger Le Verge

23 October 2007 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
MRM. Ratajczak-Enselme
M. Ratajczak-Enselme
JEJ.-P. Estebe
J.-P. Estebe
FRF.-X. Rose
F.-X. Rose
EWE. Wodey
E. Wodey
JMJ.-M. Malinovsky
J.-M. Malinovsky
Pascal Le CorrePascal Le Corre
Pascal Le Corre
Local vasoconstriction induced by epinephrine added to epidural local anaesthetics has been shown to improve their quality and duration of action in several clinical reports. There are several assumptions on the mechanisms. This study was designed to evaluate the influence of epinephrine on transmeningeal uptake of epidurally administered ropivacaine and bupivacaine by measuring local anaesthetic concentrations in the epidural and intrathecal spaces and in plasma. Ropivacaine (50 mg) and bupivacaine (30 mg) were administered epidurally in sheep with and without epinephrine (75 µg). A microdialysis technique was used to simultaneously measure epidural and intrathecal drug concentrations. Resulting dialysate and plasma concentrations were used to calculate pharmacokinetic parameters for ropivacaine and bupivacaine. Co-administration of epinephrine decreased epidural clearance for ropivacaine [0.6 (sd 0.1) vs 0.4 (0.1) ml min−1] but not significantly for bupivacaine [1.2 (0.4) vs 0.8 (0.3) ml min−1]. The resultant increase in epidural area under the concentration–time curves (31% for ropivacaine and 52% for bupivacaine) was also observed in the intrathecal space (21% increase for ropivacaine and 37% for bupivacaine). There was no significant influence of epinephrine on ropivacaine plasma pharmacokinetics. Plasma Cmax for bupivacaine was decreased. These results show that epinephrine decreases the clearance and distribution processes involved in epidural disposition of ropivacaine and bupivacaine, leading to an increased uptake into the intrathecal space with an apparent more pronounced effect for bupivacaine.